Regarding markers of inflammation and apoptosis, 84% of patients with high CASP8 concentration in CS blood (CASP8CS) (4th Q) had a recurrence, whereas only 39% of patients with low CASP8CS concentration (1st Q) suffered a recurrence (p = 0.027). This evidence concerns the gene CASP8 and Cowden syndrome 1.